Differential cancer risk and survival in Indian oral cancer patients with genic region FAS and FASL polymorphisms

  • Sarika Daripally
    CSIR-SRF, Research and Development, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India

    Registered PhD Student, Acharya Nagarjuna University, Andhra Pradesh, India
    Search for articles by this author
  • Kiranmayi Peddi
    Reprint requests: Dr. Kiranmayi Peddi Department of Biochemistry Acharya Nagarjuna University Nagarjuna Nagar Guntur Andhra Pradesh 522210 India.
    Assistant Professor, Department of Biochemistry, Acharya Nagarjuna University, Guntur, Andhra Pradesh, India
    Search for articles by this author
Published:September 19, 2021DOI:


      To investigate the association of genic region polymorphisms of FAS and FASL in Indian patients with oral cancer.

      Study design

      The study included 960 consenting control participants and patients with oral cancer. Genotyping was performed using Polymerase Chain Reaction -Restriction Fragment Length Polymorphism (PCR-RFLP). Cancer risk, 5-year survival, and hazards ratio (HRs), with respect to risk and clinical factors, were estimated using Fisher's exact test, Kaplan-Meier analysis, and Cox proportional hazards models.


      FASL IVS2nt-124 ‘AG’ increased risk in males with buccal mucosa cancer (BMC) but decreased risk in females. FAS 21196 ‘CT’ decreased risk of tongue cancer (TC) and BMC in females. The survival of the patients also differed between sexes in TC and BMC. FAS 21196 ‘CT’ increased HR by 23-fold in females with BMC when adjusted for age, stage, grade, LVS, PNI, tobacco use, and alcohol. ‘TT’ genotype increased the HR in females with BMC when adjusted for age, stage, grade, lymphovascular spread (LVS), perineural invasion (PNI), and perinodal spread (PNS). Our bioinformatic study revealed the presence of CTCF binding regions and CpG islands near FAS and FASL.


      These single nucleotide polymorphisms (SNPs) altered the risk and survival of BMC and TC patients differentially that varied with clinical and risk factors.
      To read this article in full you will need to make a payment


        • Kim JW
        • Wieckowski E
        • Taylor DD
        • Reichert TE
        • Watkins S
        • Whiteside TL.
        Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
        Clin Cancer Res. 2005; 11: 1010-1020
        • Rehman S
        • Saba N
        • Naz M
        • et al.
        Single-nucleotide polymorphisms of FAS and FASL genes and risk of idiopathic aplastic anemia.
        Immunol Invest. 2018; 47: 484-491
        • Dogru G
        • Ay OI
        • Erdal ME
        • Ay ME
        • Tombak A
        • Karakas U.
        The role of certain gene polymorphisms involved in the apoptotic pathways in polycythemia vera and essential thrombocytosis.
        Adv Clin Exp Med. 2017; 26: 761-765
        • Kassouf N
        • Thornhill MH.
        Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
        Oral Oncol. 2008; 44: 672-682
        • Chien MH
        • Chang WM
        • Lee WJ
        • et al.
        A Fas ligand (FasL)-fused humanized antibody against tumor-associated glycoprotein 72 selectively exhibits the cytotoxic effect against oral cancer cells with a low FasL/Fas ratio.
        Mol Cancer Ther. 2017; 16: 1102-1113
        • Hashemi M
        • Fazaeli A
        • Ghavami S
        • et al.
        Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.
        PloS One. 2013; 8: e53075
        • Pu X
        • Roth JA
        • Hildebrandt MA
        • et al.
        MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.
        Cancer Res. 2013; 73: 1867-1875
        • Zhang F
        • Sturgis EM
        • Sun Y
        • et al.
        Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
        Int J Cancer. 2015; 137: 2454-2461
        • Sharma S
        • Satyanarayana L
        • Asthana S
        • Shivalingesh KK
        • Goutham BS
        • Ramachandra S.
        Oral cancer statistics in India on the basis of first report of 29 population-based cancer registries.
        J Oral Maxillofac Pathol. 2018; 22: 18-26
        • Kim JS
        • Park MR
        • Lee SY
        • et al.
        Licochalcone A induces apoptosis in KB human oral cancer cells via a caspase-dependent FasL signaling pathway.
        Oncol Rep. 2014; 31: 755-762
        • Zepeda-Nuño JS
        • Guerrero-Velázquez C
        • Del Toro-Arreola S
        • et al.
        Expression of ADAM10, Fas, FasL and Soluble FasL in patients with oral squamous cell carcinoma (OSCC) and their association with clinical-pathological parameters.
        Pathol Oncol Res. 2017; 23: 345-353
        • Karimi MY
        • Kapoor V
        • Sharma SC
        • Das SN.
        Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians.
        Cancer Invest. 2013; 31: 1-6
        • Su WW
        • Su CW
        • Chang DC
        • et al.
        Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases.
        Head Neck. 2019; 41: 1475-1483
        • Rusthoven K
        • Ballonoff A
        • Raben D
        • Chen C.
        Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.
        Cancer. 2008; 112: 345-351
        • Liu SA
        • Wang CC
        • Jiang RS
        • Lee FY
        • Lin WJ
        • Lin JC.
        Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - a singe institute's experience in Taiwan.
        Sci Rep. 2017; 7: 7451
        • Liao CT
        • Huang SF
        • Chen IH
        • et al.
        Tongue and buccal mucosa carcinoma: is there a difference in outcome?.
        Ann Surg Oncol. 2010; 17: 2984-2991
        • Trivedi TI
        • Tankshali RA
        • Goswami JV
        • Shukla SN
        • Shah PM
        • Shah NG.
        Identification of site-specific prognostic biomarkers in patients with oral squamous cell carcinoma.
        Neoplasma. 2011; 58: 217-226
        • Nair S
        • Singh B
        • Pawar PV
        • et al.
        Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities.
        Eur Arch Otorhinolaryngol. 2016; 273: 3921-3928
        • Farsi NJ
        • Rousseau MC
        • Schlecht N
        • et al.
        Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
        Carcinogenesis. 2017; 38: 1188-1195
        • Daripally S
        • Nallapalle SR
        • Katta S
        • Prasad VV.
        Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
        Tumour Biol. 2015; 36: 7817-7830
        • Hlavaty T
        • Pierik M
        • Henckaerts L
        • et al.
        Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
        Aliment Pharmacol Ther. 2005; 22: 613-626
        • Rodriguez S
        • Gaunt TR
        • Day IN.
        Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies.
        Am J Epidemiol. 2009; 169: 505-514
        • Dayem Ullah AZ
        • Lemoine NR
        • Chelala C
        A practical guide for the functional annotation of genetic variations using SNPnexus.
        Brief Bioinform. 2013; 14: 437-447
        • Desmet FO
        • Hamroun D
        • Lalande M
        • Collod-Béroud G
        • Claustres M
        • Béroud C.
        Human Splicing Finder: an online bioinformatics tool to predict splicing signals.
        Nucleic Acids Res. 2009; 37: e67
        • Kent WJ
        • Sugnet CW
        • Furey TS
        • et al.
        The human genome browser at UCSC.
        Genome Res. 2002; 12: 996-1006
        • Daripally S
        • Peddi K.
        5-year cumulative survival of oral cancer patients with FAS and FASL SNPs.
        Meta Gene. 2021; 27100826
        • Wang LH
        • Ting SC
        • Chen CH
        • et al.
        Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
        J Oral Pathol Med. 2010; 39: 155-161
        • Niemela JE
        • Hsu AP
        • Fleisher TA
        • Puck JM.
        Single nucleotide polymorphisms in the apoptosis receptor gene TNFRSF6.
        Mol Cell Probes. 2006; 20: 21-26
        • Bonzheim I
        • Geissinger E
        • Chuang WY
        • et al.
        Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.
        J Hematop. 2008; 1: 11-21
        • Li C
        • Larson D
        • Zhang Z
        • et al.
        Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
        Pharmacogenet Genomics. 2006; 16: 253-263
        • Zhang Z
        • Wang LE
        • Sturgis EM
        • et al.
        Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
        Clin Cancer Res. 2006; 12: 5596-5602
        • Qureshi A
        • Nan H
        • Dyer M
        • Han J.
        Polymorphisms of FAS and FAS ligand genes and risk of skin cancer.
        J Dermatol Sci. 2010; 58: 78-80
        • Fransen NL
        • Crusius JBA
        • Smolders J
        • et al.
        Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.
        Brain Pathol. 2020; 30: 106-119
        • Ho T
        • Li G
        • Zhao C
        • Zheng R
        • Wei Q
        • Sturgis EM.
        Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis.
        Head Neck. 2008; 30: 297-305
        • Basolo F
        • Giannini R
        • Faviana P
        • et al.
        Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene.
        J Endocrinol. 2004; 182: 479-484